Nasdaq Approves First Injective Staked ETF Under Ticker INJC

Key Facts

Nasdaq has approved the first-ever Injective staked ETF, which will trade under the ticker symbol INJC. Coinpedia reported that the fund is structured to track the asset while aiming to stake approximately 90% of its holdings through providers such as BitGo, offering traditional investors exposure to the Injective ecosystem.

Technical data indicates that Injective is forming an accumulation base around $8.45, with market participants closely monitoring the $12 to $15 resistance zone. According to Coinpedia, clearing these levels could trigger a faster upward move, with some analysts identifying a potential long-term target of $60 if current catalysts persist.